AbbVie, Janssen to withdraw FDA accelerated approvals of IMBRUVICA in MCL and MZL
Janssen Pharmaceutical revealed that the FDA advised that the primary outcomes from the two phase 3 confirmatory studies…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
07 Apr 23
Janssen Pharmaceutical revealed that the FDA advised that the primary outcomes from the two phase 3 confirmatory studies…
07 Apr 23
EDP-323 is backed by in vitro data that showed a significant reduction in RSV replication with picomolar potency…
06 Apr 23
Under the agreement, Proxygen will receive an upfront payment of up to $2.55bn in research, development, and commercial…
06 Apr 23
DUO-O is a phase 3 trial to evaluate the efficacy and safety of Imfinzi in combination with platinum-based…
06 Apr 23
The comprehensive collection of nearly 100 stories, articles and immersive video delve into the strategies, community partnerships and…
06 Apr 23
Brand to expand rapidly in 2023 with addition of new retail partners and expanded production capabilities Do Good Chicken®, the
06 Apr 23
Grab your superhero-suits and get ready to take on the day! One of the most beloved cereal brands is uniting
06 Apr 23
This software is the newest addition to the BIOMÉRIEUX VISION SUITE – the company’s portfolio of Data and…
06 Apr 23
$5,000 donation to DonorsChoose marks the partnership's commitment to ensuring school sports can thrive in local communities.
06 Apr 23
Coca‑Cola introduces a new global brand campaign and platform, A Recipe for Magic, celebrating the magic of shared meals and